Dos and Do nots in Health Technology Assessments

Understand What is HTA - What it is Not

• Definitions
• Different types of HTA and the wide variety across countries
• 15 Key Principles

Thresholds Used by HTA Bodies in ICER-based Decision Making

• Recap of basic health economic principles (e.g. QALY, ICER ...)
• The variety of thresholds used across HTA bodies and how they influence decision making

Selecting from the Wide Range of Criteria

• Exploring the assessment criteria in HTA and their relative weight
• Using Multi-Criteria Decision Analysis (MCDA) to determine weights and influence decision making
• Trading off between criteria

Issues & Solutions for Optimising the Quality of the Evidence

• EMA trials versus HTA trials
• Reconciling the need for RRR vs. ARR data
• When to do ITT vs. when Per Protocol
• Compliance and Persistence are not synonyms!
• Extrapolating short term clinical data and surrogate endpoints
• Dealing with indirect effects

Effectively Working with HTA Processes Across the EU

• The optimal HTA process: does it exist?
• Learn from differences between countries
• The benefits and risks of international cooperation
• Adaptive HTA and contracts based on outcomes guarantees

Summary of Dos and Do nots and final discussion

Closing

Price: Standard: EUR 1470

Speakers: Prof. Dr. Lieven Annemans

Time: 10:00 am - 5:30 pm